BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was -186.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was -13.86K shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-03-31 was 14.06K shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 13.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 1.58K shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 2.49K shares, a 97.16% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | -186.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 13.00 shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 199.00 shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | -13.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 199.00 shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 14.06K shares 10-Q · filed 2023-05-10 | 14.06K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 0.00 shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 0.00 shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 1.58K shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | 1.58K shares 10-Q · filed 2021-05-13 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | 2.49K shares 10-K · filed 2019-04-02 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 69.79K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -17.12K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 2.49K shares 10-Q · filed 2018-05-10 | -17.12K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 67.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 87.54K shares 10-K · filed 2018-03-16 |
| 2017-09-30 | -86.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 181.76K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 268.67K shares derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | 107.15K shares 10-Q · filed 2017-05-11 | 268.67K shares derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | 161.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 161.52K shares 10-K · filed 2017-03-30 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | 0.00 shares derived: sum of 4 quarters · filed 2016-10-17 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 0.00 shares derived: sum of 4 quarters · filed 2016-08-02 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-03 | 0.00 shares derived: sum of 4 quarters · filed 2016-05-03 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 0.00 shares 10-K · filed 2016-03-25 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 0.00 shares 10-K · filed 2016-03-25 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | 0.00 shares derived: sum of 4 quarters · filed 2014-08-06 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 0.00 shares 10-K · filed 2014-03-24 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-24 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-24 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 0.00 shares 10-K · filed 2014-03-24 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | |
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |